YilmazSAkbogaMKArasDTopalogluS. Evaluation of the predictive value of CHA(2)DS(2)-VASc score for in-stent restenosis. Angiology. 2018;69(1):38–42.
2.
KornowskiRHongMKTioFOBramwellOWuHLeonMB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224–230.
3.
WeltFGRogersC. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22(11):1769–1776.
4.
YilmazSAkbogaMKSenF, et al.Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–966.
5.
CelikIEYarliogluesMKurtulA, et al.Preprocedural albumin levels and risk of in-stent restenosis after coronary stenting with bare-metal stent. Angiology. 2016;67(5):478–783.
6.
AlsancakYCengelAAkyelA, et al.Relationship between serum vitamin D levels and angiographic severity and extent of coronary artery disease. Eur J Clin Invest. 2015;45(9):940–948.
7.
AkyelASahinarslanAKiziltuncE, et al.Neutrophil gelatinase-associated lipocalin levels in isolated coronary artery ectasia. Can J Cardiol. 2011;27(6):773–778.
8.
AkbogaMKYalcinRSahinarslanAYilmaz DemirtasCAbaciA. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323–327.
9.
YilmazSSenFAkbogaMK, et al.The relationship between resting heart rate and SYNTAX score in patients with stable coronary artery disease. Angiology. 2017;68(2):168–173.
10.
KocasCAbaciOKocasBB, et al.Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation. Int J Cardiol. 2016;203:529–531.
